Dexmedetomidine Suppresses Sevoflurane Anesthesia-Induced Neuroinflammation Through Activation of the PI3K/Akt/mTOR Pathway

BMC Anesthesiology - United Kingdom
doi 10.1186/s12871-019-0808-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Alantolactone Suppresses Human Osteosarcoma Through the PI3K/AKT Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Angelica Sinensis Promotes Myotube Hypertrophy Through the PI3K/Akt/mTOR Pathway

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2014English

Emodin-Induced Autophagy Against Cell Apoptosis Through the PI3K/AKT/mTOR Pathway in Human Hepatocytes

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

JTC-801 Suppresses Melanoma Cells Growth Through the PI3K‑Akt‑mTOR Signaling Pathways

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

Astragaloside Ⅳ Combating Liver Cirrhosis Through the PI3K/Akt/mTOR Signaling Pathway

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway

Cancer Management and Research
Oncology
2019English

Gambogic Acid Suppresses Inflammation in Rheumatoid Arthritis Rats via PI3K/Akt/mTOR Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Inhibition of Esophageal Cancer Growth Through the Suppression of PI3K/AKT/mTOR Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy